Top 25 Life Science Startup Investors in Sweden (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Inventure
VC Fund
|
3 | Finland, Sweden, United States | Seed, Series A, Series B | Software, Information Technology, Health Care | $549k–$23M |
|
Almi Invest
VC Fund
|
3 | Sweden, United States, Ukraine | Seed, Pre-Seed | Software, Health Care, Information Technology | $174k–$2.2M |
|
Crowberry Capital
VC Fund
|
3 | Iceland, Denmark, Finland | Seed, Series A, Pre-Seed | Software, Gaming, Health Care | $1k–$17M |
|
Noaber
VC Fund
|
2 | The Netherlands, Israel, Sweden | Seed, Series A | Health Care, Medical, Fitness | $1.3M–$20M |
|
Norrsken VC
VC Fund
|
2 | Sweden, Germany, United Kingdom | Seed, Series A | Software, Health Care, Food and Beverage | $1.1M–$27M |
|
Mikael Lonn
Angel
|
1 | Sweden | Series A | Medical, Life Science, Biotechnology | |
|
Jens Mogensen
Angel
|
1 | Sweden | Series A | Medical, Life Science, Biotechnology | |
|
HealthCap
VC Fund
|
1 | United States, Sweden, France | Series B, Series A | Biotechnology, Health Care, Medical | $5.7M–$88M |
|
Per Båtelson
Angel
|
1 | Sweden, United States | Seed, Angel | Medical, Health Care, Medical Device | $1.4M–$4M |
|
Josefin Landgård
Angel
|
1 | Sweden, France | Seed, Angel, Pre-Seed | Health Care, Mobile, Medical | $400k–$5.3M |
|
SEB Venture Capital
VC Fund
|
1 | Sweden, Denmark, United Kingdom | Series A, Series B | Software, Information Technology, FinTech | $1.2M–$23M |
|
Länsförsäkringar
VC Fund
|
1 | Sweden | Seed, Pre-Seed | Real Estate, Biotechnology, Manufacturing | $484k–$1.1M |
|
Sofinnova Partners
VC Fund
|
1 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $6M–$102M |
|
Industrifonden
VC Fund
|
1 | Sweden, United States, Denmark | Series A, Seed | Software, Biotechnology, Information Technology | $1.1M–$21M |
|
Hampus Jakobsson
Angel
|
1 | Sweden, Denmark, United States | Seed, Angel, Series A | Health Care, Software, Artificial Intelligence | $96k–$33M |
|
GOBIA Enterprises
VC Fund
|
1 | Sweden | Seed | Eyewear, Health Care, Health Diagnostics | |
|
GU Ventures
VC Fund
|
1 | Sweden | Seed, Series A | Medical, Health Care, Pharmaceutical | $810k–$2.9M |
|
Unruly Capital
VC Fund
|
1 | United Kingdom, United States, Germany | Seed, Pre-Seed | Biotechnology, CleanTech, Clean Energy | $548k–$9.2M |
|
Nordic Science Investments
VC Fund
|
1 | Finland, Sweden | Seed, Pre-Seed, Series A | Biotechnology, Medical, Health Diagnostics | $380k–$4.6M |
|
Erik Byrenius
Angel
|
1 | Sweden, United States, Belgium | Seed, Pre-Seed, Angel | Health Care, Security, Software | $233k–$2.1M |
|
Navigare Ventures
VC Fund
|
1 | Sweden, Denmark | Seed, Pre-Seed | Biotechnology, Health Care, Energy | |
|
Sciety
VC Fund
|
1 | Sweden, Ukraine | Seed, Series A | Health Care, Biotechnology, Medical | $128k–$6.3M |
|
Voima Ventures
VC Fund
|
1 | Finland, Sweden, Norway | Seed, Pre-Seed | Biotechnology, Health Care, Artificial Intelligence | |
|
Monesi
VC Fund
|
1 | Sweden | Pre-Seed | Life Science, Biotechnology | |
|
Annexstruktur
VC Fund
|
1 | Sweden | Series A | Medical, Life Science, Biotechnology | |
| Access all 45 investors in Sweden Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A, Series B
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 164
- Round size: Seed $549k–$6M; Series A $1.3M–$17M; Series B $1.3M–$23M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $169M in 2022
Portfolio highlights
- Omocom — Omocom offers safe, simple and secure insurance for all kind of renting, sharing and re-using, digitally, automated and integrated into the sales flow of the platform
- Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
- Blueprint Genetics — We offer complete genetic testing and genetic diagnostics to medical professionals worldwide. Learn more about our winning clinical-grade NGS offering!
Almi Invest is Sweden’s most active early-stage venture capital firm, investing in scalable startups across Sustainability, Industry, Tech, and Life Science.We invest from pre-seed to Series A, always co-investing with independent private investors to accelerate innovation and long-term success. Our portfolio spans sustainable solutions,industrial innovation, deep tech, SaaS, and life science, supporting startups that drive economic and environmental progress.With €430 million under management and over 1,000 investments since 2009, we have backed leading companies like MIPS, Tobii, and Neo4j, with notable exits to Google, Apple, Microsoft, and Qlik.Beyond capital, we offer engaged ownership, providing strategic guidance, active board participation, and access to an extensive investor network.Almi Invest is part of the Almi Group and is funded by the European Regional Development Fund, Almi AB, and regional partners.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Sweden, United States, Ukraine
Investor stats
- Total investments: 263
- Round size: Seed $174k–$2.2M; Pre-Seed $236k–$1.3M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Indevex AB — Indevex is a science-based and privately owned biotech company from Sweden. A natural and reliable partner, providing evidence based natural nutrition concepts based on the patented NGC™ Formula.
- Xaga Surgical — Xaga Surgical aims to minimize the risk of infections by inventing safer medical needles.
- Inhalation Sciences — The PreciseInhale patented aerosol generation R&D platform delivers respirable dry powder aerosols from preclinical cell studies all the way through to human clinical trials, significantly accelerating drug development timelines. The platform’s one-animal-at-a-time system requires just milligrams, not grams of costly test substance for a fullPK study and delivers high-resolution lung data of, typically, <10% SD. We carry out Contract Research for novel and generic inhalation drug developers, toxicology and environmental research institutes and university research institutes in the inhalation and aerosolization field.
Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.
Show more...Investment focus
- Industry: Software, Gaming, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Iceland, Denmark, Finland
Investor stats
- Total investments: 45
- Round size: Seed $1.6M–$4.7M; Pre-Seed $1k–$1.3M; Series A $5.7M–$17M
- Lead/follow: 51% lead, 49% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Quanscient — We are building next generation simulation software-as-a-service utilizing Quantum computing algorithms. Our specialty domain of simulations is Computational Electromagnetics.
- Hemi Health — Hemi Health is a Danish digital-first headache and migraine clinic specializing in diagnosis, personalized treatment, and care for headaches using technology like an app for symptom tracking and video consultations.
- Porcelain Fortress — Porcelain Fortress was founded by a small band of romantics in the summer of 2016 in Reykjavik, Iceland.
Noaber Ventures invests in initiatives that bring social transformations using information technology.
Show more...Investment focus
- Industry: Health Care, Medical, Fitness
- Stage:Seed, Series A
- Geography: The Netherlands, Israel, Sweden
Investor stats
- Total investments: 19
- Round size: Seed $1.3M–$6.3M; Series A $3M–$20M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Plasmacure — Plasmacure develops innovative plasma technology for wound care. Discover how cold plasma is transforming the treatment of chronic wounds.
- Mirantus Health — Mirantus is building a distributed healthcare provider to improve access to care for underserved patients. Through healthcare services (Mirantus Care) and cloud-solutions (Mirantus OS), Mirantus empowers doctors to efficiently treat patients who were difficult to reach before. This improves healthcare access for patients, allows physicians to earnmore, while saving payors billions in downstream costs. Mirantus is on a mission to get every specialist physician in Europe to participate in distributed healthcare, to improve healthcare access for 100M+ underserved patients.
- Alba Health — Discover your baby's gut health & microbiome for the best start in life.
We are a venture capital fund investigating in Start-Ups solving the worlds biggest problems while building massive businesses.
Show more...Investment focus
- Industry: Software, Health Care, Food and Beverage
- Stage:Seed, Series A
- Geography: Sweden, Germany, United Kingdom
Investor stats
- Total investments: 94
- Round size: Seed $1.1M–$11M; Series A $4.2M–$27M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $340M in 2024
Portfolio highlights
- Sunsave — Save money on your bills and gain energy independence with Sunsave solar panel and battery solutions. Get a free quote today.
- Ankar AI — Your AI Operating System for Patents
- Sava Technology — SAVA is reinventing health monitoring with a novel biosensing platform enabling real-time, affordable, and painless molecular monitoring.
Mikael Lonn is an Angel Investor.
Show more...Investment focus
- Industry: Medical, Life Science, Biotechnology
- Stage:Series A
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Thioredoxin Systems — Thioredoxin Systems AB is developing an innovative antibiotic regimen for complicated urinary tract infections caused by antibiotic-resistant bacteria. The
Jens Mogensen is an Angel Investor.
Show more...Investment focus
- Industry: Medical, Life Science, Biotechnology
- Stage:Series A
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Thioredoxin Systems — Thioredoxin Systems AB is developing an innovative antibiotic regimen for complicated urinary tract infections caused by antibiotic-resistant bacteria. The
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United States, Sweden, France
Investor stats
- Total investments: 121
- Round size: Series A $5.7M–$55M; Series B $14M–$88M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $209M in 2019
Portfolio highlights
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- HelloBetter — HelloBetter (hellobetter.de) was founded in 2015 under the name GET.ON Institut für Online Gesundheitstrainings GmbH (geton-institut.de) by internationally renowned research psychologists, and in close partnership with one of the largest public health care insurance companies in Germany (BARMER). HelloBetter is a pioneer in the field of e-mentalhealth and a leading provider of online mental health courses. Its work has a strong scientific basis – the courses were developed, evaluated, and implemented in a practice setting, and their effectiveness has been proven in 33 randomized controlled trials according to the highest standards of scientific practice. HelloBetter offers the widest range of evidence-based online mental health courses worldwide, with 11 digital courses covering 8 problem areas (stress, depression, insomnia, depression in the case of chronic illness, chronic pain, alcohol consumption, excessive worry, and panic and anxiety).In October 2021, the digital therapeutic 'HelloBetter Stress and Burnout' has been permanently approved by the German Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by prescription free of charge for more than 50 million adults. It is the world’s first and so far only prescription digital therapeutic for the treatment of burnout symptoms.Through diverse cooperations with national and international research groups (including FAU Erlangen, University of Ulm, VU Amsterdam, and Harvard University) HelloBetter finds practical applications for the latest research innovations. Our products and our team have been awarded numerous national and international prizes. These include the Novartis & Sandoz/Hexal Digital Health Prize 2018, the Comenius Award of the European Federation of Psychologists’ Association, and the Good Practice in Mental Health & Wellbeing seal of approval as part of the EU Compass 2018, which recognises high-quality mental health initiatives in Europe in order to guide health care providers to effective and proven services.
- Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
Per Båtelson
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Seed, Angel
- Geography: Sweden, United States
Investor stats
- Total investments: 5
- Round size: Seed $1.4M–$4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.
- Valar Labs — AI to Make Oncologists Smarter
- Imaginecare — Imaginecare is a self-care support that helps patients with long-term health challenges to a better life. Imaginecare consists of a technical platform supplemented with a range of services and analysis tools that together offer a complete solution for healthcare.
Josefin Landgård is the Founder and CEO of Mantle. Previously she served as the Co-Founder and COO at KRY back in March 2014 to September 2018.
Show more...Investment focus
- Industry: Health Care, Mobile, Medical
- Stage:Seed, Angel, Pre-Seed
- Geography: Sweden, France
Investor stats
- Total investments: 8
- Round size: Seed $400k–$5.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Estmn — Estrid is an online portal that offers women's personal care products.
- Lassie — Lassie is the first proactive and preventive pet insurance company that wants to help pet owners take better care of their pets
- Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!SEB Venture Capital is a Fintech investor that helps entrepreneurs and innovators launch and grow profitable businesses. They primarily serve as a strategic corporate venture focused on Fintech investments, with the option of partnering with SEB. They are also on the hunt for game-changing inventive solutions to new technologies that will make thefinancial industry smarter, safer, and more environmentally responsible, as well as more user-friendly. They also function as an evergreen fund, giving them the flexibility and staying strength to focus on long-term wealth development depending on what is best for the firm and its shareholders.
Show more...Investment focus
- Industry: Software, Information Technology, FinTech
- Stage:Series A, Series B
- Geography: Sweden, Denmark, United Kingdom
Investor stats
- Total investments: 70
- Round size: Series A $1.2M–$11M; Series B $2.2M–$23M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $300M in 1995
Portfolio highlights
- Apica — The Operational Data Fabric from Apica unifies and connects all your data using a revolutionary Active Observability architecture.
- MobileTag — Mobile Tag, the European leader in mobile barcode solutions, continues to innovate with the launch of its latest application: mobiletag Universal Reader and shopping.Mobile Tag is behind the creation of the flashcode, the standard 2D barcode used by operators in France. This type of Datamatrix barcode is used by the biggest companies indisplay, transportation, distribution, the pharmaceutical industry, and more.Mobile Tag has always tried to develop new technology from the consumer's point of view, and the mobiletag Universal Reader & shopping is no exception.The concept behind this application is to send, receive and share information and best prices to everyone and for everyone through all standardized barcodes.Scanning a barcode with your mobile phone is simply taking a picture of it with your phone, using the mobiletag application. Mobile tag is free!
- CorPower Ocean — CorPower Ocean AB was founded in 2009 to develop high efficiency Wave Energy Converters (WECs).CorPower's Wave Energy Converters deliver five times higher annual energy output per ton of device compared to previously known wave power solutions. The step-change improvement in performance and efficiency allows a Cost-of-Energy that cancompete with offshore wind. The products are currently in pilot with Iberdrola. CorPower has assembled a team with extensive experience in energy generation, design and manufacturing of production equipment, system engineering as well as the market expertise to allow us to continue transforming the technology of tomorrow into renewable energy applications of today.
Länsförsäkringar is a Swedish group of public insurance companies.
Show more...Investment focus
- Industry: Real Estate, Biotechnology, Manufacturing
- Stage:Seed, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 12
- Round size: Seed $484k–$1.1M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Stendorren Fastigheter — Stendorren Fastigheter is a company involved in the real estate industry. It develops, owns, operates, and maintains industrial, logistical, and warehouse facilities. The business offers adequate and suitable space on fair lease terms through its tenant.
- pixlbio (formerly Phenaros) — Data-centric drug discovery with AI, Phenomics and Automation.
- Swedish Logistic Property — Swedish Logistic Property (SLP) specializes in the development and management of logistics properties across Sweden. With a focus on energy efficiency, SLP provides modern logistics solutions tailored to meet the needs of various businesses. The company's portfolio includes strategically located properties designed to support efficientlogistics and supply chain operations. SLP also engages in the acquisition and development of new properties, aiming to expand its footprint in the logistics real estate market. The company's commitment to sustainability is evident in its construction practices and the operation of its logistics facilities.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 298
- Round size: Series A $6M–$65M; Series B $10M–$102M; Series C $11M–$100M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- protera — Protera is advancing the science of protein engineering to address some of the most critical problems and opportunities in food, agriculture, the environment and human health. We streamline protein design and development with MADI, our proprietary deep learning algorithm, to predict high value protein products and enzymes with unprecedented speed.Our in-house lab generates small quantities of the new predicted structures to validate their desired performance. Upon lab validation, we collaborate with our clients on next steps to move from pilot to industrial scale production.
- Bioptimus — Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
- T-Therapeutics — T-Therapeutics is a expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration. .
Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Series A, Seed
- Geography: Sweden, United States, Denmark
Investor stats
- Total investments: 174
- Round size: Seed $1.1M–$6.3M; Series A $3.3M–$21M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- Novatron — A new fusion reactor design for stable plasma confinement and fusion power generation.
- Open Payments — Open Payments connects you to multiple banks through one single unified API. This removes the complexity and frictions of many diverse integrations
- Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
Hampus Jakobsson is a General Partner at early stage climate tech venture fund Pale Blue Dot.Prior to co-founding Pale Blue Dot, Hampus was a Venture Partner at science fund Blue Yard and a prolific angel investor with >100 angel investments. He co-founded of The Astonishing Tribe (acquired by Blackberry in 2010 for $150m). He left Blackberry2012 to found Brisk.io a sales productivity tool which folded 2016.
Show more...Investment focus
- Industry: Health Care, Software, Artificial Intelligence
- Stage:Seed, Angel, Series A
- Geography: Sweden, Denmark, United States
Investor stats
- Total investments: 43
- Round size: Seed $310k–$5.3M; Angel $96k–$1.2M; Series A $2.3M–$33M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- LifeX — LifeX offers furnished and serviced private rooms in coliving apartments or private apartments in central locations in Copenhagen, London, Paris, Berlin, Munich, Halle and Aarhus. Enjoy all-inclusive prices, flexible rental terms and a built-in community of young professionals.
- Neurolabs — Neurolabs helps puts an end to out-of-stocks using a powerful combination of computer vision and synthetic data, improving customer experience and increasing revenue.
- ClimateView — ClimateView is a Swedish climate action technology company that helps cities transform climate planning into progress. We combine data, agent-based modelling and interface design to help cities successfully manage the transition to zero carbon economies.
GOBIA Enterprises is owned by Jan G Smith who has been active in the pharmaceutical industry.
Show more...Investment focus
- Industry: Eyewear, Health Care, Health Diagnostics
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Profundus Imaging — Profundus' retinal imaging technology enables researchers and clinicians in particular to visualise subclinical changes of retinal disease.
- Thioredoxin Systems — Thioredoxin Systems AB is developing an innovative antibiotic regimen for complicated urinary tract infections caused by antibiotic-resistant bacteria. The
GU Ventures build businesses out of groundbreaking ideas that help shape a better tomorrow. Our passionate team of company builders, financial experts, IP and legal talent ensure success for our companies.
Show more...Investment focus
- Industry: Medical, Health Care, Pharmaceutical
- Stage:Seed, Series A
- Geography: Sweden
Investor stats
- Total investments: 6
- Round size: Seed $810k–$2.9M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- NSS Water —
- Profundus Imaging — Profundus' retinal imaging technology enables researchers and clinicians in particular to visualise subclinical changes of retinal disease.
- Thioredoxin Systems — Thioredoxin Systems AB is developing an innovative antibiotic regimen for complicated urinary tract infections caused by antibiotic-resistant bacteria. The
Investing in the crazy before it becomes normal
Show more...Investment focus
- Industry: Biotechnology, CleanTech, Clean Energy
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 51
- Round size: Seed $1.3M–$9.2M; Pre-Seed $548k–$2.6M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- 4QT — Cleantech, Construction, Electrification
- AtmoCooling — AtmoCooling transforms coastal deserts into thriving hubs of agriculture, clean energy, and climate resilience. It was founded in 2022 and operates in the USA and UAE.
- Applied Atomics, Inc. — Co-located nuclear power plants to unlock the next 1,000 years of advanced industry.
We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Diagnostics
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden
Investor stats
- Total investments: 10
- Round size: Seed $1.1M–$4.6M; Pre-Seed $380k–$837k
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- AIATELLA — Automating medical image analysis
- CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
- SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.
Erik Byrenius is a founding partner of Mudcake, a microfund run by ex-founders dedicated to making the world a better place for the next generation. We invest in the strongest founders shaping the way we produce, distribute and consume food. Our typical ticket is $200k-$600k in pre-seed and seed rounds globally.Previously he was the CEO andco-founder of food delivery business OnlinePizza (exit to Delivery Hero), founder of StartupTools and co-founded the angel syndicate Nordic Makers.
Show more...Investment focus
- Industry: Health Care, Security, Software
- Stage:Seed, Pre-Seed, Angel
- Geography: Sweden, United States, Belgium
Investor stats
- Total investments: 12
- Round size: Seed $360k–$2.1M; Pre-Seed $233k–$1.6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Digitail — Grow your practice, offer a modern client experience, and automate routine practice tasks with the proven all-in-one veterinary software.
- Mavenoid — Mavenoid is the only product support automation platform built for complex products and devices. Using our unique AI, we solve problems too complex for chatbots
- Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Whether you are an investor or entrepreneur, partner with Sciety to achieve impactful returns and elevate your life science business in the Nordics.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: Sweden, Ukraine
Investor stats
- Total investments: 44
- Round size: Seed $128k–$2.3M; Series A $439k–$6.3M
- Lead/follow: 93% lead, 7% follow
Portfolio highlights
- Capitainer — Capitainer enables patients to collect their own volume-defined dried blood spot at home.Capitainer started in 2016. Their technology is a volumetric blood collection device that enables patients to conveniently and safely collect blood samples in the comfort of their own home, our technology is more accurate than today’s solutions. Capitaineroffers impressive cost and environmental savings for healthcare providers managing millions of conventional blood samples annually.
- SAGA Diagnostics — SAGA Diagnostics AB is a personalized cancer diagnostics and disease monitoring company focused on molecular genetic analyses of a powerful cancer biomarker: circulating tumor DNA (ctDNA). The company was founded in 2016 as a spin-out from a highly successful research group at Lund University, with a mission to improve precision cancer medicine,provide more accurate treatment monitoring, and improve patient survival using minimally-invasive liquid biopsy cancer testing services and kits.The SAGA team consists of renowned scientists, highly qualified staff and an experienced management team who work together to launch SAGA’s ultrasensitive services and products as part of the ongoing revolution in cancer research, drug development, and clinical diagnostics. SAGA’s proprietary tests can help patients, oncologists, and drug developers detect actionable mutations, stratify patient groups, and monitor treatment response, residual disease, and disease recurrence at an unprecedented sensitivity.
- Single Technologies — Founded in Stockholm, Sweden, with its long tradition in fiber optics, ultra-sensitive fluorescence spectroscopy and DNA sequencing, SINGLE’s ambition is to become the instigator of 3-D Sequencing.
Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: Finland, Sweden, Norway
Investor stats
- Total investments: 54
- Lead/follow: no public data
Portfolio highlights
- Farang — Farang is an AI research lab based in Sweden developing the next-generation of foundational Large Language Models. The company was founded in 2025 and consists of a team of highly experienced researchers, developers, entrepreneurs and business professionals, joined by prominent deep-tech VCs and angel investors.
- Kuva Space — Kuva Space improves life on Earth through daily, space-borne hyperspectral imaging and AI. We offer Earth observation solutions for more sustainable business.
- MVision AI — AI-powered solutions that automate repetitive tasks, enable efficient radiotherapy workflows, and promote consistency across clinical processes.
Monesi is an invesment firm.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- pixlbio (formerly Phenaros) — Data-centric drug discovery with AI, Phenomics and Automation.
Annexstruktur is a venture capital firm that provides investments to companies.
Show more...Investment focus
- Industry: Medical, Life Science, Biotechnology
- Stage:Series A
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Thioredoxin Systems — Thioredoxin Systems AB is developing an innovative antibiotic regimen for complicated urinary tract infections caused by antibiotic-resistant bacteria. The
Life Science Investor funding in Sweden at a glance
Stats across 28 deals from 45 investors.
Access all 45 investors in Sweden Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Investors in Sweden investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 45 investors investing in Sweden Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!